Open Journal of Obstetrics and Gynecology, 2020, 10, 526-537 https://www.scirp.org/journal/ojog ISSN Online: 2160-8806 ISSN Print: 2160-8792 DOI: 10.4236/ojog.2020.1040047 Apr. 20, 2020 526 Open Journal of Obstetrics and Gynecology Medical Management of Cesarean Scar Pregnancy at Latifa Hospital Dubai Health Authority, Dubai, UAE A. Ammar 1 , F. Nasrallah 1 , H. Adan 1 , J. Ali 1 , M. Mussa 1 , A. B. E. Fazari 1,2* , N. Alsawalhee 1 1 Latifa Hospital for Women & Children, DHA, Dubai, UAE 2 University of Medical Sciences & Technology, Khartoum, Sudan Abstract Introduction: Cesarean scar pregnancy (CSP) is defined as implantation of gestational sac at the site of cesarean scar. It’s a serious diagnosis that has be- come more prevalent in recent years and related to the increasing rate of ce- sarean sections reported worldwide. Identifying these cases and treating them is challenging, with no agreed upon universal protocol for successful treat- ment. We aim to evaluate the success rate and outcome of medical manage- ment for Cesarean scar pregnancy. Methods: It was a retrospective descrip- tive study of all cesarean scar pregnancies managed at fetal medicine unit at Latifa Hospital in Dubai, UAE the main obstetrics & Gynecology tertiary hospital in Dubai Emirate, UAE from 2015 to 2017. Certainly, a set of diag- nostic criteria were implemented to confirm the diagnosis of CSP. The cases were then offered our proposed management which is systemic methotrexate injections ± KCL. Follow up made by serial βhcg and ultrasound scan. The data were collected used specified data collection sheet for this purpose then analyzed and presented using statistical package for social sciences (SPSS) version 26. Results: 33 cases of cesarean scar pregnancies are confirmed and medically managed during the study period. The study subjects composed of a group of patients who had a viable CSP and received local KCL injection + systemic methotrexate, a second group who had non-viable CSP and received systemic methotrexate 20 cases were viable pregnancies who received com- bined local potassium chloride plus systemic methotrexate, and 13 were non-viable received systemic methotrexate only. The mean gestational age at diagnosis was 8 weeks (SD ± 1.8). On average our cases had a history of 3 previous cesarean sections (range 1 - 6). Overall, the success rate calculated from our study population for medical management of CSP was 77.8%; this varied between viable CSP which had a success rate of 66.7% and non-viable How to cite this paper: Ammar, A., Na- srallah, F., Adan, H., Ali, J., Mussa, M., Fazari, A.B.E. and Alsawalhee, N. (2020) Medical Management of Cesarean Scar Pregnancy at Latifa Hospital Dubai Health Authority, Dubai, UAE. Open Journal of Obstetrics and Gynecology, 10, 526-537. https://doi.org/10.4236/ojog.2020.1040047 Received: March 19, 2020 Accepted: April 17, 2020 Published: April 20, 2020 Copyright © 2020 by author(s) and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access